Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 1
2009 3
2012 1
2013 1
2014 2
2015 3
2016 1
2018 1
2019 4
2020 2
2021 5
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Zahedi-Seresht
Page 1
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.
Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, O'Hear C, Huang H, Kwan A, Li CC, Piccione EC, Wei MC, Yin S, Bartlett NL. Budde LE, et al. J Clin Oncol. 2022 Feb 10;40(5):481-491. doi: 10.1200/JCO.21.00931. Epub 2021 Dec 16. J Clin Oncol. 2022. PMID: 34914545 Free PMC article. Clinical Trial.
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia.
Shadman M, Goodrich A. Shadman M, et al. J Adv Pract Oncol. 2020 Apr;11(3):312-315. doi: 10.6004/jadpro.2020.11.3.19. Epub 2020 Apr 1. J Adv Pract Oncol. 2020. PMID: 33598332 Free PMC article.
Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events associated with approved t
Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved a
Tear Metabolomics in Dry Eye Disease: A Review.
Yazdani M, Elgstøen KBP, Rootwelt H, Shahdadfar A, Utheim ØA, Utheim TP. Yazdani M, et al. Int J Mol Sci. 2019 Aug 1;20(15):3755. doi: 10.3390/ijms20153755. Int J Mol Sci. 2019. PMID: 31374809 Free PMC article. Review.
RECTAL FOREIGN BODY PRESENTING AS CHRONIC DIARRHEA: A CASE REPORT.
Pashaei MR, Tarvirdinasab S, Jazayeri M, Najafinia K, Pashaei B, Mobaraki K, Ahmadzadeh J. Pashaei MR, et al. Gastroenterol Nurs. 2021 Jan-Feb 01;44(1):55-59. doi: 10.1097/SGA.0000000000000566. Gastroenterol Nurs. 2021. PMID: 33464767 No abstract available.
Does precision decrease with set size?
Mazyar H, van den Berg R, Ma WJ. Mazyar H, et al. J Vis. 2012 Jun 8;12(6):10. doi: 10.1167/12.6.10. J Vis. 2012. PMID: 22685337 Free PMC article.
28 results